We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
1051
Best Buy
BBY
$18B
$2.11M 0.01%
26,282
+4,894
+23% +$360K
ALLY icon
1052
Ally Financial
ALLY
$13.6B
$2.11M 0.01%
86,158
+16,405
+24% +$436K
QDPL icon
1053
Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF
QDPL
$1.78B
$2.1M 0.01%
73,584
-1,950
-3% -$56.6K
HPQ icon
1054
HP
HPQ
$28.6B
$2.1M 0.01%
78,132
+3,822
+5% +$106K
VONV icon
1055
Vanguard Russell 1000 Value ETF
VONV
$22B
$2.1M 0.01%
31,493
+2,679
+9% +$176K
USXF icon
1056
iShares ESG Advanced MSCI USA ETF
USXF
$1.52B
$2.09M 0.01%
68,072
+26,039
+62% +$789K
PKG icon
1057
Packaging Corp of America
PKG
$22.9B
$2.09M 0.01%
16,312
+2,057
+14% +$258K
NDAQ icon
1058
Nasdaq
NDAQ
$54.6B
$2.08M 0.01%
33,837
+1,264
+4% +$78.7K
VCLT icon
1059
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.8B
$2.08M 0.01%
27,423
-353
-1% -$26.5K
BAH icon
1060
Booz Allen Hamilton
BAH
$9.43B
$2.07M 0.01%
19,795
-518
-3% -$53.8K
PPH icon
1061
VanEck Pharmaceutical ETF
PPH
$991M
$2.07M 0.01%
26,593
+23,339
+717% +$1.72M
CTAS icon
1062
Cintas
CTAS
$80.3B
$2.06M 0.01%
18,276
-2,124
-10% -$230K
DIV icon
1063
Global X SuperDividend US ETF
DIV
$780M
$2.06M 0.01%
109,814
-6,670
-6% -$126K
CFA icon
1064
VictoryShares US 500 Volatility Wtd ETF
CFA
$556M
$2.05M 0.01%
30,312
+10,876
+56% +$728K
TPL icon
1065
Texas Pacific Land
TPL
$23.9B
$2.05M 0.01%
7,884
-243
-3% -$64.4K
GNL icon
1066
Global Net Lease
GNL
$1.9B
$2.05M 0.01%
163,050
-6,582
-4% -$81.6K
RISR icon
1067
FolioBeyond Alternative Income and Interest Rate Hedge ETF
RISR
$316M
$2.05M 0.01%
64,888
+19,165
+42% +$601K
BCE icon
1068
BCE
BCE
$21.7B
$2.04M 0.01%
46,411
+2,482
+6% +$112K
SPXX icon
1069
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$346M
$2.04M 0.01%
126,220
+320
+0.3% +$5.32K
NEA icon
1070
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$2.03M 0.01%
178,715
-12,764
-7% -$139K
BUFF icon
1071
Innovator Laddered Allocation Power Buffer ETF
BUFF
$944M
$2.03M 0.01%
59,015
+9,157
+18% +$312K
ASO icon
1072
Academy Sports + Outdoors
ASO
$3.03B
$2M 0.01%
38,168
-6,191
-14% -$295K
EIX icon
1073
Edison International
EIX
$27.2B
$2M 0.01%
31,436
-1,287
-4% -$79K
JPME icon
1074
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$479M
$2M 0.01%
23,743
+7,392
+45% +$619K
WHR icon
1075
Whirlpool
WHR
$2.79B
$2M 0.01%
14,113
-43
-0.3% -$6.11K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.